Akili Interactive, a company known for pioneering cognitive treatments using game-changing technologies, has reached a definitive agreement to be acquired by Virtual Therapeutics. The acquisition, valued at $0.4340 per share in cash, has been approved by the boards of both companies and is expected to close in Q3 2024 pending certain conditions. The transaction aims to form a leading digital health company. Goodwin advised Akili on the deal, with a multidisciplinary team spanning various legal domains.

Digital Health, Life Sciences, Mergers and Acquisitions (M&A),United States